![Jag Ahluwalia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jag Ahluwalia
Keine laufenden Positionen mehr
Profil
Jag Ahluwalia worked as an Executive Director-Global Regulatory Affairs at PLIVA, Inc. and held Principal positions at Johnson & Johnson, Quintiles, Inc. (California), Janssen-Cilag International NV, and Ranbaxy (U.K.) Ltd.
She also worked as a Vice President-Quality & Regulatory Affairs at Xellia Pharmaceuticals ApS.
Ahluwalia received her undergraduate degree from The University of Nottingham and her graduate degree from the University of Surrey.
Ehemalige bekannte Positionen von Jag Ahluwalia
Unternehmen | Position | Ende |
---|---|---|
Xellia Pharmaceuticals ApS
![]() Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Janssen-Cilag International NV
![]() Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Quintiles, Inc. (California)
![]() Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Ranbaxy (U.K.) Ltd.
![]() Ranbaxy (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Ranbaxy (UK) Ltd. engages in the distribution of generic and branded generic pharmaceuticals to wholesalers and pharmacy chains. The company was founded in 1994 and is headquartered in Hayes, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Jag Ahluwalia
The University of Nottingham | Undergraduate Degree |
University of Surrey | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 5 |
---|---|
PLIVA, Inc.
![]() PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Retail Trade |
Ranbaxy (U.K.) Ltd.
![]() Ranbaxy (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Ranbaxy (UK) Ltd. engages in the distribution of generic and branded generic pharmaceuticals to wholesalers and pharmacy chains. The company was founded in 1994 and is headquartered in Hayes, the United Kingdom. | Health Technology |
Quintiles, Inc. (California)
![]() Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Janssen-Cilag International NV
![]() Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
Xellia Pharmaceuticals ApS
![]() Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Services |